Rifampin-Associated Flu-Like Syndrome in a Patient Undergoing Treatment for a Device-Related Infection

Area of Science:

• Infectious Diseases
• Pharmacology

Background:

• Rifampin (or rifampicin) is a key antibiotic for treating tuberculosis and device-related infections.
• Antimicrobial therapy is crucial for managing persistent infections, especially those involving medical devices.

Observation:

• A patient developed a flu-like syndrome during prolonged rifampin treatment for discitis and a device-related infection.
• The syndrome emerged during daily dosing of rifampin, a regimen common for device infections.

Findings:

• Discontinuation of rifampin led to the prompt resolution of the flu-like syndrome.
• This case highlights a potential adverse effect of rifampin in the context of device-related infections.

Implications:

• Clinicians should consider flu-like symptoms as a potential adverse reaction to rifampin, even with daily dosing for device infections.
• Further research may be needed to understand the incidence and mechanisms of rifampin-induced flu-like illness in various treatment contexts.